Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
epidermal growth factor receptor | 0.295 | 0.885 | 0.37 |
|
group | 0.600 | None | 0.984 | 80 | 0 | 1994 | 2019 | ||||||||
|
tumor protein p53 | 0.236 | 0.962 | 0.53 |
|
group | 0.800 | None | 0.974 | 43 | 0 | 1990 | 2019 | ||||||||
|
glutathione S-transferase mu 1 | 0.380 | 0.923 | 2.1E-03 |
|
group | 0.400 | None | 1.000 | 18 | 0 | 1994 | 2012 | ||||||||
|
prostaglandin-endoperoxide synthase 2 | 0.314 | 0.962 | 1.00 |
|
group | 0.100 | None | 1.000 | 17 | 0 | 2002 | 2018 | ||||||||
|
cyclin dependent kinase inhibitor 2A | 0.300 | 0.885 | 0.39 |
|
group | 0.800 | None | 1.000 | 14 | 0 | 1997 | 2019 | ||||||||
|
KRAS proto-oncogene, GTPase | 0.320 | 0.923 | 7.9E-04 |
|
group | 0.600 | None | 0.974 | 13 | 0 | 1991 | 2019 | ||||||||
|
cytochrome P450 family 1 subfamily A member 1 | 0.436 | 0.846 | 1.1E-17 |
|
group | 0.100 | None | 1.000 | 13 | 0 | 1994 | 2018 | ||||||||
|
glutathione S-transferase pi 1 | 0.383 | 0.923 | 1.4E-02 |
|
group | 0.600 | None | 1.000 | 12 | 0 | 2002 | 2009 | ||||||||
|
erb-b2 receptor tyrosine kinase 2 | 0.328 | 0.923 | 6.0E-03 |
|
group | 0.400 | None | 1.000 | 11 | 0 | 1992 | 2019 | ||||||||
|
vascular endothelial growth factor A | 0.266 | 0.923 | 2.4E-05 |
|
group | 0.100 | None | 1.000 | 11 | 0 | 1999 | 2019 | ||||||||
|
X-ray repair cross complementing 1 | 0.421 | 0.923 | 6.3E-09 |
|
group | 0.100 | None | 1.000 | 10 | 0 | 2002 | 2010 | ||||||||
|
Ras association domain family member 1 | 0.420 | 0.808 | 4.9E-06 |
|
group | 0.400 | None | 1.000 | 10 | 0 | 2000 | 2018 | ||||||||
|
ERCC excision repair 2, TFIIH core complex helicase subunit | 0.420 | 0.846 | 7.1E-20 |
|
group | 0.100 | None | 1.000 | 9 | 0 | 2002 | 2010 | ||||||||
|
glutathione S-transferase theta 1 | 0.393 | 0.923 | 1.5E-04 |
|
group | 0.390 | None | 1.000 | 9 | 0 | 2002 | 2008 | ||||||||
|
fragile histidine triad diadenosine triphosphatase | 0.444 | 0.846 | 5.7E-03 |
|
group | 0.400 | None | 1.000 | 9 | 0 | 1996 | 2013 | ||||||||
|
MDM2 proto-oncogene | 0.362 | 0.846 | 1.00 |
|
group | 0.100 | None | 1.000 | 9 | 0 | 1995 | 2019 | ||||||||
|
matrix metallopeptidase 9 | 0.305 | 0.923 | 1.9E-17 |
|
group | 0.100 | None | 1.000 | 9 | 0 | 2002 | 2018 | ||||||||
|
baculoviral IAP repeat containing 5 | 0.495 | 0.731 | 5.6E-02 |
|
group | 0.390 | None | 1.000 | 9 | 0 | 2004 | 2009 | ||||||||
|
O-6-methylguanine-DNA methyltransferase | 0.412 | 0.885 | 1.2E-07 |
|
group | 0.100 | None | 1.000 | 8 | 0 | 1999 | 2013 | ||||||||
|
ERCC excision repair 1, endonuclease non-catalytic subunit | 0.445 | 0.846 | 1.6E-07 |
|
group | 0.580 | None | 1.000 | 8 | 0 | 2003 | 2018 | ||||||||
|
C-X-C motif chemokine receptor 4 | 0.362 | 0.923 | 1.8E-02 |
|
group | 0.100 | None | 1.000 | 8 | 0 | 2004 | 2015 | ||||||||
|
telomerase reverse transcriptase | 0.374 | 0.846 | 0.99 |
|
group | 0.400 | None | 1.000 | 8 | 0 | 2000 | 2017 | ||||||||
|
matrix metallopeptidase 2 | 0.333 | 0.923 | 0.84 |
|
group | 0.100 | None | 1.000 | 7 | 0 | 2002 | 2018 | ||||||||
|
myeloperoxidase | 0.377 | 0.923 | 7.1E-15 |
|
group | 0.370 | None | 1.000 | 7 | 0 | 2002 | 2008 | ||||||||
|
AKT serine/threonine kinase 1 | 0.311 | 0.962 | 0.98 |
|
group | 0.500 | None | 1.000 | 7 | 0 | 2003 | 2019 |